Bioject Medical Technologies Inc., together with its subsidiaries, develops, manufactures, and distributes needle-free injection therapy systems (NFITS) in the United States and internationally. The companys NFITS work by forcing liquid medication at high speed through a tiny orifice held against the skin. It offers Biojector 2000, a refinement of jet injection technology that enables healthcare professionals to deliver measured variable doses of medication through the skin, either intramuscularly or subcutaneously without a needle; and drug reconstitution system that allows the transfer of diluents to reconstitute powdered medications into liquid form and withdrawal of liquid medication into a syringe without the use of a needle. Bioject Medical Technologies also offers Vitajet, which is composed of two components, a portable injector unit and a disposable syringe; and ZetaJet, a compact and spring-powered injection device intended to deliver vaccines and injectable medications either subcutaneously or intramuscularly. In addition, the company is developing Iject needle-free injection system, a single prefilled disposable injector for self-injection; Jupiter Jet, a pistol-shaped, or streamlined ergonomic gas-powered injection device for patient and professional use; and pre-filled Biojector syringes. It has a strategic alliance with MPI Research. Bioject Medical Technologies Inc. was founded in 1985 and is based in Tualatin, Oregon.